Not Just a Prescription Request: Evaluating Erectile Dysfunction in a 58-Year-Old Man as a Warning Sign for Cardiovascular Disease Before Offering a PDE5 Inhibitor
[Student Name]
University of Phoenix
NRP/556: Adult and Geriatric Management II
Week 6 Assignment
[Instructor Name]
[Date]
The patient is a composite written for a model paper.
Mr. C., a 58-year-old bus dispatcher, comes for a medication refill and, at the end of the visit, asks whether he can "get the blue pill." He has had difficulty getting and keeping erections for about a year, gradually worsening. He has hypertension on hydrochlorothiazide, has not had lipids checked in five years, smokes half a pack a day and is overweight. This paper describes the evaluation and plan.
How Common Is It
In the Massachusetts Male Aging Study, a community sample of men aged 40 to 70, about half reported some degree of erectile dysfunction, and its prevalence rose with age and was associated with heart disease, hypertension, diabetes and related medications (Feldman et al., 1994). Erectile dysfunction is common, but common does not mean unimportant.
Taking the History
The AUA guideline recommends that men presenting with erectile dysfunction undergo a thorough medical, sexual and psychosocial history, a physical examination and selected laboratory testing (Burnett et al., 2018). Mr. C. reports that the problem is gradual, occurs with his partner and with self-stimulation and that morning erections are rare, all suggesting a physical rather than psychological cause. He has no pain, curvature or urinary symptoms. His relationship is supportive. He screens negative for depression. He drinks two beers most nights.
Erectile Dysfunction as a Warning
Thompson et al. (2005), using data from the placebo arm of a prostate cancer prevention trial, followed men without cardiovascular disease and found that incident erectile dysfunction was associated with a 25% higher risk of subsequent cardiovascular events, and incident or prevalent erectile dysfunction with a 45% higher risk, after adjustment for other risk factors. The authors concluded that erectile dysfunction should prompt investigation of cardiovascular risk factors. The small penile arteries may show the effects of endothelial dysfunction before larger coronary arteries do.
He came for a pill; the history and the evidence say he came, without knowing it, for his heart.
Examination
Blood pressure 146/90 mm Hg, pulse 80, BMI 31, waist 104 cm. Genital examination normal, with no plaques or small testes. Peripheral pulses slightly reduced in the feet. No gynecomastia.
What the Examination Looks For
The examination is brief but purposeful. Blood pressure, waist and weight address cardiovascular and metabolic risk. The genital examination looks for Peyronie plaques, small or soft testes suggesting low testosterone and signs of other disease. Peripheral pulses assess vascular disease. Breast examination looks for gynecomastia, which can accompany hormonal problems.
Laboratory Testing
I order fasting glucose and A1C, a lipid panel and a morning total testosterone, as the guideline suggests measuring testosterone in men with erectile dysfunction (Burnett et al., 2018). Results: A1C 6.4%, prediabetes; LDL cholesterol 162 mg/dL; testosterone normal.
Cardiovascular Risk
His 10-year atherosclerotic cardiovascular disease risk by the pooled cohort equations is 16%, intermediate to high, driven by smoking, blood pressure, cholesterol and age. His erectile dysfunction adds to the concern. I ask about exertional chest pain or breathlessness; he denies both but rarely exerts himself. Sexual activity is similar in exertion to climbing two flights of stairs; he can climb stairs without symptoms.
Treating the Risk Factors
I start a moderate-intensity statin, discuss smoking cessation and prescribe varenicline, which he accepts, increase blood pressure treatment by adding amlodipine and refer him to a diabetes prevention program. These changes may also improve erectile function, since smoking, hypertension and dyslipidemia damage the endothelium.
Treating the Erectile Dysfunction
The guideline recommends phosphodiesterase type 5 inhibitors as a first-line option for men with erectile dysfunction, along with lifestyle change and management of comorbidities (Burnett et al., 2018). I confirm that he does not take nitrates, riociguat or alpha blockers. I prescribe sildenafil 50 mg taken about an hour before sexual activity, on an empty stomach for faster effect, and explain that sexual stimulation is still needed. Side effects include headache, flushing, nasal congestion and, rarely, visual changes.
Safety Teaching
He must never take sildenafil within 24 hours of nitroglycerin, and if he develops chest pain during sex, he must tell emergency responders that he took it. An erection lasting more than four hours requires emergency care.
The Role of Hydrochlorothiazide
Thiazide diuretics have been associated with erectile dysfunction in some men. His blood pressure needs more treatment regardless, and amlodipine, which is less associated with erectile problems, is added. If his symptoms do not improve, switching from hydrochlorothiazide to another class could be considered, although blood pressure control itself protects the vessels that erections depend on.
Talking About Sex
Many men wait years before mentioning erectile dysfunction, and many clinicians do not ask. Mr. C. raised it only at the end of a visit about something else. Asking directly and without embarrassment, and explaining that erectile problems often signal treatable health issues, makes it easier for men to seek care earlier.
His Partner
Erectile dysfunction affects both partners. I invite Mr. C. to bring his wife to a future visit if he wishes, and mention that couples counseling or sex therapy can help if relationship concerns arise.
If Sildenafil Does Not Work
If sildenafil fails after proper use at an adequate dose on at least several occasions, options include a different PDE5 inhibitor, a vacuum device, injections into the penis or referral to urology. The guideline supports discussing all options, since each has advantages and drawbacks (Burnett et al., 2018).
Alcohol
Reducing his evening drinking may improve erectile function and helps his blood pressure.
Why Testosterone Was Checked
Low testosterone can cause erectile dysfunction and reduced desire and can blunt the response to PDE5 inhibitors. Checking a morning level is recommended in the guideline's evaluation (Burnett et al., 2018). His normal level means testosterone treatment is not indicated, which avoids an unnecessary therapy with its own risks.
Cardiac Clearance for Sexual Activity
For men with known heart disease, guidelines advise assessing whether sexual activity is safe before treating erectile dysfunction. Mr. C. has no known heart disease, no symptoms with exertion and can climb stairs comfortably, so no further cardiac testing is needed before prescribing, though his risk factors will be treated aggressively.
Documentation
The note records the sexual history, the cardiovascular risk calculation, the nitrate check, the laboratory results and the safety teaching given to him.
Follow-Up
I will see him in six weeks to review blood pressure, smoking cessation, side effects and the response to sildenafil, adjusting the dose as needed.
Conclusion
Mr. C.'s erectile dysfunction was gradual, organic in pattern and accompanied by smoking, hypertension, high cholesterol and prediabetes. Trial data show erectile dysfunction predicts cardiovascular events, so the visit became a cardiovascular risk assessment that led to a statin, smoking cessation and better blood pressure control. Sildenafil, prescribed after checking for nitrates, treats the symptom he came for, while the rest of the plan treats the risk it revealed.
References
Burnett, A. L., Nehra, A., Breau, R. H., Culkin, D. J., Faraday, M. M., Hakim, L. S., Heidelbaugh, J., Khera, M., McVary, K. T., Miner, M. M., Nelson, C. J., Sadeghi-Nejad, H., Seftel, A. D., & Shindel, A. W. (2018). Erectile dysfunction: AUA guideline. Journal of Urology, 200(3), 633-641. https://doi.org/10.1016/j.juro.2018.05.004
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994). Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. Journal of Urology, 151(1), 54-61. https://doi.org/10.1016/S0022-5347(17)34871-1
Thompson, I. M., Tangen, C. M., Goodman, P. J., Probstfield, J. L., Moinpour, C. M., & Coltman, C. A. (2005). Erectile dysfunction and subsequent cardiovascular disease. JAMA, 294(23), 2996-3002. https://doi.org/10.1001/jama.294.23.2996
How this NRP 556 Week 6 example is structured
The NRP/556 Week 6 work usually addresses men's health and reproductive conditions. This paper treats a common request as a clinical opportunity, showing how the history finds contributing conditions, how evidence links the symptom to cardiovascular risk and how treatment is chosen and made safe. Students search this week as NRP 556 Week 6, NRP556 Wk 6 or NRP/556 Wk 6; all three are the same assignment.
NRP/556 Week 6 questions, answered
What does NRP/556 Week 6 usually ask for?
Many sections present a men's health or reproductive condition and ask for evaluation, differential and guideline-based management.
Why is erectile dysfunction linked to heart disease?
Both share risk factors and endothelial dysfunction. Because penile arteries are small, erectile dysfunction often appears years before coronary symptoms, making it an early warning sign.
When are PDE5 inhibitors unsafe?
They must not be taken with nitrates, such as nitroglycerin, because the combination can cause dangerous drops in blood pressure. Caution is also needed with alpha blockers and in unstable heart disease.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official University of Phoenix document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.